Ameritas Investment Partners
BEAM icon

Ameritas Investment Partners’s Beam Therapeutics BEAM Stock Holding History

Ameritas Investment Partners’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Buy
8,999
+1,011
+13% +$30.5K 0.01% 1128
2026
Q1 		$190K Hold
7,988
– – 0.01% 1289
2025
Q4 		$221K Hold
7,988
– – 0.01% 1193
2025
Q3 		$194K Sell
7,988
-1,361
-15% -$27.1K 0.01% 1255
2025
Q2 		$159K Hold
9,349
– – 0.01% 1449
2025
Q1 		$183K Buy
9,349
+1,350
+17% +$35.4K 0.01% 1317
2024
Q4 		$198K Buy
7,999
+496
+7% +$12.7K 0.01% 1326
2024
Q3 		$184K Hold
7,503
– – 0.01% 1379
2024
Q2 		$176K Hold
7,503
– – 0.01% 1362
2024
Q1 		$248K Hold
7,503
– – 0.01% 1145
2023
Q4 		$204K Buy
7,503
+713
+11% +$17.7K 0.01% 1254
2023
Q3 		$163K Buy
6,790
+1,147
+20% +$30.7K 0.01% 1315
2023
Q2 		$180K Buy
5,643
+660
+13% +$21.4K 0.01% 1196
2023
Q1 		$153K Hold
4,983
– – 0.01% 1260
2022
Q4 		$221K Hold
4,983
– – 0.01% 1081
2022
Q3 		$237K Buy
4,983
+216
+5% +$12.3K 0.01% 980
2022
Q2 		$184K Buy
4,767
+811
+21% +$32.2K 0.01% 1114
2022
Q1 		$227K Hold
3,956
– – 0.01% 1110
2021
Q4 		$315K Buy
3,956
+135
+4% +$11.6K 0.01% 954
2021
Q3 		$332K Buy
3,821
+137
+4% +$13.8K 0.01% 908
2021
Q2 		$474K Buy
3,684
+342
+10% +$27.2K 0.02% 810
2021
Q1 		$267K Hold
3,342
– – 0.01% 1033
2020
Q4 		$273K Buy
3,342
+331
+11% +$16.3K 0.01% 976
2020
Q3 		$74K Buy
3,011
+1,961
+187% +$48.6K ﹤0.01% 1610
2020
Q2 		$29K Hold
1,050
– – ﹤0.01% 2149
2020
Q1 		$19K Buy
+1,050
New +$22.8K ﹤0.01% 2202

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Nikko Asset Management Americas
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Ameritas Investment Partners's BEAM Position: Q2 2026 in Review

Ameritas Investment Partners increased its Beam Therapeutics (BEAM) stake by 13% in Q2 2026, buying an estimated $30.5K and bringing the position to 8,999 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #1128.

Ameritas Investment Partners first reported a position in BEAM in Q1 2020 and has held it in 26 quarters since. The position peaked at $474K in Q2 2021. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Ameritas Investment Partners held 8,999 shares of Beam Therapeutics worth $309K as of Q2 2026.
  • Ameritas Investment Partners bought 1,011 Beam Therapeutics shares in Q2 2026, an estimated $30.5K.
  • Beam Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1128 holding.
  • Ameritas Investment Partners first reported a position in Beam Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Ameritas Investment Partners's Beam Therapeutics position peaked at $474K in Q2 2021.
  • 277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.